Literature DB >> 15727258

Evidence for duplication of the human defensin gene DEFB4 in chromosomal region 8p22-23 and implications for the analysis of SNP allele distribution.

Michele Boniotto1, Mario Ventura, Joyce Eskdale, Sergio Crovella, Grant Gallagher.   

Abstract

Defensins constitute a primary mechanism in the innate immune system of humans and all mammals. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. In humans, four beta-defensins have been described so far, corresponding to the products of the genes DEFB1 (hBD1, NM_005218), DEFB4 (hBD2, NM_004942.2), DEFB103 (hBD3, NM_018661), and DEFB104 (hBD4, NM_080389), respectively. All these genes have been mapped to chromosome 8p22-23. Much interest has been shown in genetic variation in the population at defensin loci to understand individual differences in disease susceptibility and severity. In this study, we have used an electronic search and then fluorescence in situ hybridization (FISH) on elongated chromosomes to demonstrate that the region containing the DEFB4 gene is duplicated on human chromosome 8p, making difficult the discovery of new SNPs in this gene and compromising the assessment of their allelic distribution in various ethnic populations for disease association studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15727258     DOI: 10.1089/gte.2004.8.325

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  2 in total

1.  Copy number variation in CNP267 region may be associated with hip bone size.

Authors:  Shan-Lin Liu; Shu-Feng Lei; Fang Yang; Xi Li; Rong Liu; Shan Nie; Xiao-Gang Liu; Tie-Lin Yang; Yan Guo; Fei-Yan Deng; Qing Tian; Jian Li; Yao-Zhong Liu; Yong-Jun Liu; Hui Shen; Hong-Wen Deng
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

2.  Genome-wide association study identified CNP12587 region underlying height variation in Chinese females.

Authors:  Yin-Ping Zhang; Fei-Yan Deng; Tie-Lin Yang; Feng Zhang; Xiang-Ding Chen; Hui Shen; Xue-Zheng Zhu; Qing Tian; Hong-Wen Deng
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.